Table 2 Main results of the two groups
Outcomes | SBS group (n = 38) | SIS group (n = 27) | p value |
|---|---|---|---|
Technical success | 38 (100) | 27 (100) | 1 |
Reduction of bilirubin level | |||
By 20% at 1 week | 34 (89.5) | 18 (66.7) | 0.03 |
By 75% at 1 month | 35 (92.1) | 24 (88.9) | 0.69 |
Complications | |||
Major complication | 1 | ||
Acute renal failure | 1 (2.6) | 0 | |
Minor complications | 7 (18.4) | 9 (33.3) | 0.24 |
Cholangitis | 3 (7.9) | 8 (29.6) | 0.04 |
Cholecystitis | 1 (2.6) | 0 | 1 |
Pancreatitis | 2 (5.3) | 1 (3.7) | 1 |
Peritonitis | 1 (2.6) | 0 | 1 |
Stent occlusion | 7 (18.4) | 10 (37) | 0.09 |